ACUT Accustem Sciences, Inc.
Fundamentals / CIK 0001850767 / USDAccustem Sciences, Inc. reported $83K in total assets and a net loss of $3.12M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACUT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$3.12M Operating profit
-
Net Income FY 2025-$3.12M GAAP bottom line
-
Diluted EPS FY 2025-$0.19 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$15K Total debt: --
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Research & Development | $281K | $138K | $140K | $267K | $73K |
| Total Operating Expenses | $1.76M | $1.51M | $2.05M | $3.75M | $671K |
| Operating Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| EBITDA | -$1.76M | -$1.50M | -$2.05M | -$3.74M | -- |
| Income Before Tax | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| Net Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| Basic EPS | -$0.12 | -$0.13 | -$0.18 | -$0.34 | -$0.07 |
| Diluted EPS | -$0.12 | -$0.13 | -$0.18 | -$0.34 | -- |
| Basic Shares Outstanding | 15.2M | 11.4M | 11.3M | 11.0M | 10.0M |
| Diluted Shares Outstanding | 15.2M | 11.4M | 11.3M | 11.0M | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | $98K | -- | -- | -- | -- | -- | -- |
| Research & Development | $14K | $44K | $120K | $120K | $73K | $60K | $28K | $42K |
| Total Operating Expenses | $1.87M | $351K | $486K | $514K | $400K | $401K | $440K | $372K |
| Operating Income | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| EBITDA | -- | -- | -- | -$514K | -$400K | -$401K | -$440K | -$371K |
| Income Before Tax | -- | -- | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| Net Income | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| Basic EPS | -$0.12 | -$0.02 | -$0.03 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Diluted EPS | -$0.12 | -$0.02 | -$0.03 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Basic Shares Outstanding | 16.1M | 16.1M | 16.1M | -- | 16.1M | 16.1M | 12.7M | -- |
| Diluted Shares Outstanding | 16.1M | 16.1M | 16.1M | -- | 16.1M | 16.1M | 12.7M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14K | $5.0K | $21K | $734K | -- |
| Cash & Short-Term Investments | $14K | $5.0K | $21K | $734K | -- |
| Other Current Assets | -- | -- | -- | $30K | -- |
| Total Current Assets | $49K | $50K | $130K | $932K | $1.35M |
| Property, Plant & Equipment, Net | -- | $418 | $4.0K | $7.7K | -- |
| Total Non-Current Assets | $1.50M | $418 | $4.0K | $7.7K | $0 |
| Total Assets | $1.55M | $51K | $134K | $940K | $1.35M |
| Accounts Payable | $704K | $805K | $578K | $312K | $389K |
| Other Current Liabilities | $4.22M | $2.37M | $1.45M | $142K | -- |
| Total Current Liabilities | $4.95M | $3.36M | $2.25M | $1.08M | $703K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.95M | $3.36M | $2.25M | $1.08M | $703K |
| Common Stock | $16K | $12K | $11K | $11K | $10.0K |
| Retained Earnings | -$9.78M | -$8.03M | -$6.52M | -$4.47M | -$725K |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $67K |
| Total Stockholders' Equity | -$3.40M | -$3.31M | -$2.11M | -$140K | $651K |
| Total Equity | -$3.40M | -$3.31M | -$2.11M | -$140K | $651K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15K | $13K | $12K | $14K | $14K | $31K | $36K | $5.0K |
| Cash & Short-Term Investments | $15K | $13K | $12K | $14K | $14K | $31K | $36K | $5.0K |
| Other Current Assets | -- | -- | -- | -- | $1.50M | $1.50M | $1.50M | -- |
| Total Current Assets | $83K | $106K | $50K | $49K | $1.57M | $1.61M | $1.55M | $50K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $105 | $418 |
| Total Non-Current Assets | $0 | $1.50M | $1.50M | $1.50M | $0 | $0 | $105 | $418 |
| Total Assets | $83K | $1.61M | $1.55M | $1.55M | $1.57M | $1.61M | $1.55M | $51K |
| Accounts Payable | $640K | $616K | $738K | $704K | $923K | $860K | $849K | $805K |
| Other Current Liabilities | $5.36M | $5.02M | $4.68M | $4.22M | $3.37M | $3.07M | $2.71M | $2.37M |
| Total Current Liabilities | $6.06M | $5.72M | $5.42M | $4.95M | $4.48M | $4.15M | $3.71M | $3.36M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.06M | $5.72M | $5.42M | $4.95M | $4.48M | $4.15M | $3.71M | $3.36M |
| Common Stock | $16K | $16K | $16K | $16K | $16K | $16K | $16K | $12K |
| Retained Earnings | -$12.39M | -$10.52M | -$10.27M | -$9.78M | -$9.27M | -$8.87M | -$8.47M | -$8.03M |
| Total Stockholders' Equity | -$5.98M | -$4.12M | -$3.87M | -$3.40M | -$2.91M | -$2.53M | -$2.16M | -$3.31M |
| Total Equity | -$5.98M | -$4.12M | -$3.87M | -$3.40M | -$2.91M | -$2.53M | -$2.16M | -$3.31M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| Depreciation & Amortization | $418 | $3.6K | $3.6K | $3.3K | -- |
| Stock-Based Compensation | $89K | $70K | $79K | $134K | $21K |
| Change in Payables | -$101K | $226K | $267K | -$77K | $395K |
| Operating Cash Flow | -$850K | -$664K | -$1.62M | -$1.81M | -- |
| Capital Expenditure | -- | -- | -- | -$11K | -- |
| Free Cash Flow | -- | -- | -- | -$1.82M | -- |
| Investing Cash Flow | -- | -- | -- | -$11K | -- |
| Common Stock Issued | -- | -- | -- | $2.68M | -- |
| Financing Cash Flow | $859K | $648K | $903K | $2.55M | -- |
| Net Change in Cash | $8.9K | -$16K | -$712K | $734K | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| Depreciation & Amortization | -- | -- | -- | $0 | $105 | $105 | $313 | $907 |
| Stock-Based Compensation | $7.4K | $7.3K | $15K | $24K | $24K | $23K | $18K | $19K |
| Change in Payables | $24K | -$122K | $34K | -$219K | $63K | $11K | $44K | $14K |
| Operating Cash Flow | -$241K | -$249K | -$374K | $22K | -$604K | $22K | -$290K | $414 |
| Financing Cash Flow | $244K | $250K | $372K | -$23K | $587K | -$27K | $322K | -$32K |
| Net Change in Cash | $2.4K | $721 | -$1.7K | -$463 | -$17K | -$5.0K | $31K | -$32K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -103.1% |
| Return on Assets (ROA) | -113.3% | -2959.8% | -1531.5% | -398.7% | -49.6% |
| Current Ratio | 0.01x | 0.01x | 0.06x | 0.86x | 1.93x |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.68x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -3753.2% | -102.9% | -116.3% | -113.3% | -102.6% | -95.6% | -91.5% | -2959.8% |
| Current Ratio | 0.01x | 0.02x | 0.01x | 0.01x | 0.35x | 0.39x | 0.42x | 0.01x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x |
| Operating Cash Flow Growth (YoY) | -- | -1253.8% | -- | +5300.2% | -- | -- | -- | -- |